TP53 and Miyoshi myopathy: Here we report a novel and previously unexplored mechanistic role for GFI1 as a modulator of sphingolipid metabolism, by which it regulates survival of MM cells regardless of their p53 status (see schematic in Figure S5), and acts in addition to GFI1 inhibition of p53 WT in p53 replete cells.